AstraZeneca (AZN) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
AstraZeneca (AZN) quarterly earnings & revenue
AstraZeneca (AZN) reported revenue of $15.29B for Q1 2026, up 12.5% year-over-year, with net income of $3.08B and diluted EPS of $1.97.
Over the last four reported quarters, AstraZeneca generated $60.44B in revenue and $10.39B in net income.
AstraZeneca's next earnings report is scheduled for July 27, 2026 before market open; analysts estimate EPS of $2.52.
AstraZeneca quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q1 2026 | $15.29B | +12.5% | $3.08B | $1.97 |
| Q4 2025 | $15.50B | +4.1% | $2.33B | $1.48 |
| Q3 2025 | $15.19B | +12.0% | $2.53B | $1.62 |
| Q2 2025 | $14.46B | +11.7% | $2.45B | $1.57 |
| Q1 2025 | $13.59B | +7.2% | $2.92B | $1.87 |
| Q4 2024 | $14.89B | +23.8% | $1.50B | $0.96 |
| Q3 2024 | $13.56B | +18.0% | $1.43B | $0.92 |
| Q2 2024 | $12.94B | +13.3% | $1.93B | $1.24 |
AstraZeneca (AZN) — frequently asked questions
When does AstraZeneca (AZN) report earnings next?
AstraZeneca is expected to report earnings on July 27, 2026 before market open. Analysts estimate EPS of $2.52.
What was AZN's revenue last quarter?
AstraZeneca reported revenue of $15.29B in Q1 2026, up 12.5% from the same quarter a year earlier.
What was AZN's EPS last quarter?
AstraZeneca reported diluted EPS of $1.97 in Q1 2026.
Is AstraZeneca profitable?
AstraZeneca is currently profitable, with $10.39B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)